Page last updated: 2024-12-05

1-bromo-2-chloroethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Bromo-2-chloroethane: Structure, Properties, and Research Significance

1-Bromo-2-chloroethane is a colorless, volatile liquid with the chemical formula CH2BrCH2Cl. Its structure features a two-carbon chain with a bromine atom attached to one carbon and a chlorine atom attached to the other.

**Here are some key features and properties of 1-bromo-2-chloroethane:**

* **Molecular Weight:** 157.44 g/mol
* **Density:** 1.66 g/cm3
* **Boiling Point:** 107 °C
* **Solubility:** Insoluble in water but soluble in organic solvents like ethanol and diethyl ether
* **Reactivity:** 1-Bromo-2-chloroethane is a reactive compound that can undergo various reactions, including nucleophilic substitutions, elimination reactions, and free radical reactions.

**Why is 1-Bromo-2-chloroethane important for research?**

1-Bromo-2-chloroethane has several applications in research, primarily due to its ability to act as a **synthetic building block** for a variety of other molecules. Here are some key areas where this compound plays a role:

* **Organic Chemistry:** 1-Bromo-2-chloroethane is used in the synthesis of complex organic molecules, serving as a source of a bromoethyl group. Its reactivity allows for reactions like Grignard and Wittig reactions, which are crucial in organic synthesis.
* **Pharmaceutical Research:** The compound is used in the development of new drugs and pharmaceuticals. Its specific structure can be modified to create compounds with unique biological activities.
* **Materials Science:** Researchers utilize 1-Bromo-2-chloroethane in the synthesis of polymers and other materials with specific properties. For example, it can be used to introduce bromine functionalities into polymers, influencing their physical and chemical characteristics.
* **Environmental Research:** Due to its reactivity, 1-Bromo-2-chloroethane is also used in studies related to environmental pollution and degradation of organic compounds.

**Important Note:** 1-Bromo-2-chloroethane is a **hazardous** compound. It is flammable, corrosive, and potentially carcinogenic. Researchers handling this chemical should wear appropriate personal protective equipment (PPE) and work in a well-ventilated area.

**Conclusion:**

1-Bromo-2-chloroethane is a versatile compound with significant applications in various fields of research, particularly in organic chemistry, pharmaceutical science, and materials science. Its reactivity and ability to act as a synthetic building block make it a valuable tool for researchers striving to synthesize new and innovative molecules. However, its hazardous nature requires careful handling and appropriate safety precautions.

1-bromo-2-chloroethane : A haloalkane that is bromoethane substituted by chlorine at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7849
CHEMBL ID160255
CHEBI ID19032
SCHEMBL ID117238
MeSH IDM0118482

Synonyms (76)

Synonym
CHEBI:19032 ,
beta-chloroethyl bromide
2-bromoethyl chloride
2-bromo-1-chloroethane
1-chloro-2-bromoethane
s-chlorobromoethane
.beta.-chloroethyl bromide
nsc60186
nsc-60186
1,2-chlorobromoethane
2-chloroethyl bromide
ethylene chlorobromide
1,2-bromochloroethane
wln: g2e
inchi=1/c2h4brcl/c3-1-2-4/h1-2h
1-bromo-2-chloroethane
ethane, 1-bromo-2-chloro-
107-04-0
NCGC00091170-01
brn 0605265
ai3-52297
nsc 60186
caswell no. 436b
einecs 203-456-0
ccris 816
sym-chlorobromoethane
hsdb 6121
epa pesticide chemical code 042001
1-bromo-2-chloroethane, 98%
B0572
CHEMBL160255
NCGC00091170-02
AKOS005720772
unii-b2pdn2xo5u
b2pdn2xo5u ,
4-01-00-00155 (beilstein handbook reference)
cas-107-04-0
NCGC00257128-01
dtxsid4024775 ,
dtxcid904775
tox21_303193
tox21_201726
NCGC00259275-01
BBL011345
c2h4brcl
STL146435
ethylene bromochloride
FT-0607453
syn-chlorobromoethane
1-bromo-2-chloroethane [hsdb]
BR1051
SCHEMBL117238
ch2brch2cl
2-bromo-1-chloro-ethane
brch2ch2cl
bromo-2-chloroethane
2-chloroethylbromide
2-chloro-1-bromoethane
1-bromo 2-chloroethane
1-bromo 2-chloro ethane
2-chlorobromoethane
1-bromo-2-chloro-ethane
bromo 2 chloroethane
2-bromochloroethane
1-bromo-2-chloro ethane
2-bromo-l-chloroethane
1-chloro-2-bromo-ethane
Q-200110
F0001-0135
mfcd00000962
Q27109104
AMY25520
FS-4503
D95298
EN300-31848
1-bromo-2-chloroethane 1000 microg/ml in methanol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
haloalkaneA halohydrocarbon that is an alkane in which at least one hydrogen atom has been replaced by with a halogen atom.
organobromine compoundA compound containing at least one carbon-bromine bond.
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
farnesoid X nuclear receptorHomo sapiens (human)Potency61.64480.375827.485161.6524AID743217
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency44.66840.001024.504861.6448AID588534
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency38.45310.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID37562Induction of aneuploidy in Aspergillus nidulans.1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID19825Partition coefficient (logP)1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's4 (50.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.52 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index54.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]